REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sinaifarm S.A. (Ecuador)

Main Activities: Pharmacies and Drug Stores
Full name: Sinaifarm S.A. Profile Updated: February 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Sinaifarm S.A. is a company in Ecuador, with a head office in Cuenca. It operates in the Pharmacies and Drug Stores sector. It was incorporated on August 21, 1998. 53 (2024) employees currently work for Sinaifarm S.A.. From the latest financial highlights, Sinaifarm S.A. reported a net sales revenue increase of 10.16% in 2024. During that time, Sinaifarm S.A.’s total assets grew by 12.93%. In, 2024, the company’s net profit margin increased by 1.08%.

Headquarters
Miguel Cordero 6-140, Edificio Consultorios Monte Sinai Bldg.
Cuenca; Azuay;

Contact Details: Purchase the Sinaifarm S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Sinaifarm S.A. report to view the information.
Registered Capital:
Purchase the Sinaifarm S.A. report to view the information.
Financial Auditors:
Purchase the Sinaifarm S.A. report to view the information.
Incorporation Date:
August 21, 1998
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
99.99%
Purchase this report to view the information.
0.01%
Company Performance
Financial values in the chart are available after Sinaifarm S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
10.16%▲
Total operating revenue
10.4%▲
Operating profit (EBIT)
40.88%▲
EBITDA
44.62%▲
Net Profit (Loss) for the Period
29.77%▲
Total assets
12.93%▲
Total equity
20.67%▲
Operating Profit Margin (ROS)
2.62%▲
Net Profit Margin
1.08%▲
Return on Equity (ROE)
2.95%▲
Debt to Equity Ratio
-2.08%▼
Quick Ratio
0.12%▲
Cash Ratio
0.13%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo